left
Hey There : )
right
Blog
Planify Feed
Pharmeasy has determined the Conversion Price of the CCPS Series-A
    • news

    Pharmeasy has determined the Conversion Price of the CCPS Series-A

    20 September 2023

    The company has determined the CCPS Series-A Conversion Price in accordance with the terms and conditions mentioned in a resolution passed by the Board meeting dated May 15, 2023, at ₹ 4.356 per share, which corresponds to a maximum of up to 125,88,32,279 equity shares to be issued upon the conversion of CCPS-A. 

    Image

    Stay Connected, Stay Informed –

    Join Our

    WhatsApp

    Channel!

    Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.